Anticancer property of Bryophyllum pinnata (Lam.) Oken. leaf on human cervical cancer cells

BMC Complementary and Alternative Medicine

Volumn 12, Issue , 2012, Pages

  Mahata, Sutapa ^a   Maru, Saurabh ^a   Shukla, Shirish ^a   Pandey, Arvind ^a   Mugesh, G ^b   Das, Bhudev C ^c   Bharti, Alok C ^a  

^a Institute of Cytology and Preventive Oncology ICMR   (India)

^b INDIAN INSTITUTE OF SCIENCE   (India)

^c UNIVERSITY OF DELHI   (India)

Author keywords

AP1; Bryophyllum pinnata; Hela cells; HPTLC; Human papillomavirus; NMR

Indexed keywords

ACETIC ACID ETHYL ESTER; BRYOPHYLLUM PINNATA EXTRACT; CASPASE 3; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; OCTAMER TRANSCRIPTION FACTOR 1; PETROLEUM ETHER; PLANT EXTRACT; PROTEIN BAX; PROTEIN BCL 2; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; ANTIVIRUS AGENT; BRYOPHYLLIN A; BUFADIENOLIDE DERIVATIVE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN C FOS; PROTEIN C JUN;

ANTINEOPLASTIC ACTIVITY; ANTIVIRAL ACTIVITY; APOPTOSIS; ARTICLE; BOTANY; BRYOPHYLLUM PINNATA; CANCER GROWTH; CANCER INHIBITION; CELL VIABILITY; COLUMN CHROMATOGRAPHY; CONTROLLED STUDY; CYTOTOXICITY; DNA BINDING; DOWN REGULATION; ENZYME ACTIVATION; FEMALE; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; HIGH PERFORMANCE THIN LAYER CHROMATOGRAPHY; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 18; IC 50; IMMUNOBLOTTING; MEDICINAL PLANT; NORTHERN BLOTTING; NUCLEAR MAGNETIC RESONANCE; ONCOGENE C FOS; ONCOGENE C JUN; PHYTOCHEMISTRY; PLANT LEAF; PROTEIN BINDING; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; THIN LAYER CHROMATOGRAPHY; UTERINE CERVIX CANCER; VIRUS INHIBITION; VIRUS TRANSCRIPTION; CELL PROLIFERATION; CHEMISTRY; DRUG EFFECT; GENETICS; ISOLATION AND PURIFICATION; KALANCHOE; METABOLISM; PAPILLOMA VIRUS; PAPILLOMAVIRUS INFECTION; PATHOGENICITY; PHYTOTHERAPY; TUMOR CELL LINE; UTERINE CERVIX TUMOR; VIROLOGY;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTIVIRAL AGENTS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BUFANOLIDES; CASPASE 3; CELL LINE, TUMOR; CELL PROLIFERATION; DOWN-REGULATION; FEMALE; HUMANS; INHIBITORY CONCENTRATION 50; KALANCHOE; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PHYTOTHERAPY; PLANT EXTRACTS; PLANT LEAVES; POLY(ADP-RIBOSE) POLYMERASES; PROTO-ONCOGENE PROTEINS C-BCL-2; PROTO-ONCOGENE PROTEINS C-FOS; PROTO-ONCOGENE PROTEINS C-JUN; TRANSCRIPTION FACTOR AP-1; UTERINE CERVICAL NEOPLASMS;

EID: 84857933581     PISSN: None     EISSN: 14726882     Source Type: Journal    
DOI: 10.1186/1472-6882-12-15     Document Type: Article

References (44)

1. Tan G, Gyllenhaal C, Soejarto DD. Biodiversity as a source of anticancer drugs. Curr Drug Targets 2006, 7(3):265-277. 10.2174/138945006776054942, 16515527.
2. Akinpelu DA. Antimicrobial activity of Bryophyllum pinnatum leaves. Fitoterapia 2000, 71(2):193-194. 10.1016/S0367-326X(99)00135-5, 10727819.
3. Misra SaD SN. Antifungal activity of leaf extract of some higher plants. Acta Botanica Indica 1979, 7:147-150.
4. Pal S, Nag Chaudhuri AK. Studies on the anti-ulcer activity of a Bryophyllum pinnatum leaf extract in experimental animals. J Ethnopharmacol 1991, 33(1-2):97-102. 10.1016/0378-8741(91)90168-D, 1943181.
5. Pal S, Nag Chaudhuri AK. Preliminary studies on the anti-inflammatory and analgesic activities of bryophyllum pinnatum (Lam.). Med Sci Res 1989, 17:561-562.
6. Pal S, Nag Chaudhuri AK. Further studies on the anti-inflammatory profile of the methanolic fraction of the fresh leaf extract of bryophyllum pinnatum. Fitoterapia 1992, 63:451-459.
7. Ojewole JAO. Antihypertensive properties of bryophyllum pinnatum (Clam; oken) leaf extracts. Am J Hypert 2002, 15(4):A34-A39.
8. Ojewole JA. Antinociceptive, anti-inflammatory and antidiabetic effects of Bryophyllum pinnatum (Crassulaceae) leaf aqueous extract. J Ethnopharmacol 2005, 99(1):13-19. 10.1016/j.jep.2005.01.025, 15848014.
9. Umbuzeiro-Valent G, Roubicek DA, Haebisch EM. Mutagenic and antimutagenic evaluation of the juice of the leaves of Bryophyllum calycinum (Kalanchoe pinnata), a plant with antihistamine activity. Environ Mol Mutagen 1999, 33(4):325-327. 10.1002/(SICI)1098-2280(1999)33:4<325::AID-EM10>3.0.CO;2-E, 10398381.
10. Gaind KN, Gupta RL. Flavonoid glycosides from Kalanchoe pinnata. Planta Med 1971, 20(4):368-373.
11. Marriage PB, Wilson DG. Analysis of the organic acids of Bryophyllum calycinum. Can J Biochem 1971, 49(3):282-296. 10.1139/o71-041, 5549729.
12. Muzitano MF, Falcao CA, Cruz EA, Bergonzi MC, Bilia AR, Vincieri FF, Rossi- Bergmann B, Costa SS. Oral metabolism and efficacy of Kalanchoe pinnata flavonoids in a murine model of cutaneous leishmaniasis. Planta Med 2009, 75(4):307-311. 10.1055/s-0028-1088382, 19085683.
13. Muzitano MF, Tinoco LW, Guette C, Kaiser CR, Rossi-Bergmann B, Costa SS. The antileishmanial activity assessment of unusual flavonoids from Kalanchoe pinnata. Phytochemistry 2006, 67(18):2071-2077. 10.1016/j.phytochem.2006.06.027, 16930642.
14. Torres-Santos EC, Da Silva SA, Costa SS, Santos AP, Almeida AP, Rossi-Bergmann B. Toxicological analysis and effectiveness of oral Kalanchoe pinnata on a human case of cutaneous leishmaniasis. Phytother Res 2003, 17(7):801-803. 10.1002/ptr.1242, 12916081.
15. Muzitano MF, Cruz EA, de Almeida AP, Da Silva SA, Kaiser CR, Guette C, Rossi-Bergmann B, Costa SS. Quercitrin: an antileishmanial flavonoid glycoside from Kalanchoe pinnata. Planta Med 2006, 72(1):81-83. 10.1055/s-2005-873183, 16450304.
16. Da-Silva SA, Costa SS, Rossi-Bergmann B. The anti-leishmanial effect of Kalanchoe is mediated by nitric oxide intermediates. Parasitology 1999, 118(Pt 6):575-582.
17. Cao H, Xia J, Xu D, Lu B, Chen G. The separation and identification of the flavonoids from the leaves of Bryophyllum pinnatum. Zhong Yao Cai 2005, 28(11):988-990.
18. Parkin DM. The global health burden of infection-associated cancers in the year 2002. Int J Cancer 2006, 118(12):3030-3044. 10.1002/ijc.21731, 16404738.
19. Durst M, Gissmann L, Ikenberg H, zur Hausen H. A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. Proc Natl Acad Sci USA 1983, 80(12):3812-3815. 10.1073/pnas.80.12.3812, 394142, 6304740.
20. Boshart M, Gissmann L, Ikenberg H, Kleinheinz A, Scheurlen W, zur Hausen H. A new type of papillomavirus DNA, its presence in genital cancer biopsies and in cell lines derived from cervical cancer. EMBO J 1984, 3(5):1151-1157. 557488, 6329740.
21. zur Hausen H. Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis. J Natl Cancer Inst 2000, 92(9):690-698. 10.1093/jnci/92.9.690, 10793105.
22. Chen HC, Schiffman M, Lin CY, Pan MH, You SL, Chuang LC, Hsieh CY, Liaw KL, Hsing AW, Chen CJ. Persistence of type-specific human papillomavirus infection and increased long-term risk of cervical cancer. J Natl Cancer Inst 2011, 103(18):1387-1396. 10.1093/jnci/djr283, 21900119.
23. Zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2002, 2(5):342-350. 10.1038/nrc798, 12044010.
24. Satoru Kyo DJK, Masaki I, Taro K, Laimins LA. Expression of AP1 during cellular differentiation determines human papillomavirus E6/E7 expression in stratified epithelial cells. J Gen Virol 1997, 78:401-411.
25. Butz K, Hoppe-Seyler F. Transcriptional control of human papillomavirus (HPV) oncogene expression: composition of the HPV type 18 upstream regulatory region. J Virol 1993, 67(11):6476-6486. 238084, 8411351.
26. Prusty BK, Das BC. Constitutive activation of transcription factor AP-1 in cervical cancer and suppression of human papillomavirus (HPV) transcription and AP-1 activity in HeLa cells by curcumin. Int J Cancer 2005, 113(6):951-960. 10.1002/ijc.20668, 15514944.
27. Bharti AC, Shukla S, Mahata S, Hedau S, Das BC. Anti-human papillomavirus therapeutics: facts & future. Indian J Med Res 2009, 130(3):296-310.
28. Mahata S, Bharti AC, Shukla S, Tyagi A, Husain SA, Das BC. Berberine modulates AP-1 activity to suppress HPV transcription and downstream signaling to induce growth arrest and apoptosis in cervical cancer cells. Mol Cancer 2011, 10:39. 10.1186/1476-4598-10-39, 3098825, 21496227.
29. Shukla S, Bharti AC, Hussain S, Mahata S, Hedau S, Kailash U, Kashyap V, Bhambhani S, Roy M, Batra S, et al. Elimination of high-risk human papillomavirus type HPV16 infection by 'Praneem' polyherbal tablet in women with early cervical intraepithelial lesions. J Cancer Res Clin Oncol 2009, 135(12):1701-1709. 10.1007/s00432-009-0617-1, 19526249.
30. Zhengyin Yan GC. Evaluation of cytochrome P450 inhibition in human liver microsomes. Optimization in drug discovery: in vitro methods 2004, 231-244. Totowa, NJ: Humana press, Zhengyin Yan GWC.
31. Yamagishi T, Haruna M, Yan XZ, Chang JJ, Lee KH. Antitumor agents, 110. Bryophyllin B, a novel potent cytotoxic bufadienolide from Bryophyllum pinnatum. J Nat Prod 1989, 52(5):1071-1079. 10.1021/np50065a025, 2607348.
32. Emmanuel E, Obaseiki-Ebor KO, Telikepalli H, Mitscher Lester A, Delbert M. Shankel: Antimutagenic activity of extracts of leaves of four common edible vegetable plants in Nigeria (West Africa). Mutat Res Lett 1993, 302(2):109-117.
33. Eferl R, Wagner EF. AP-1: a double-edged sword in tumorigenesis. Nat Rev Cancer 2003, 3(11):859-868. 10.1038/nrc1209, 14668816.
34. el SA A, Zhu Q, Shah ZI, Wani G, Barakat BM, Racoma I, El-Mahdy MA, Wani AA. Thymoquinone up-regulates PTEN expression and induces apoptosis in doxorubicin-resistant human breast cancer cells. Mutat Res 2011, 706(1-2):28-35. 10.1016/j.mrfmmm.2010.10.007, 3037029, 21040738.
35. Bharti AC, Donato N, Singh S, Aggarwal BB. Curcumin (diferuloylmethane) down-regulates the constitutive activation of nuclear factor-kappa B and IkappaBalpha kinase in human multiple myeloma cells, leading to suppression of proliferation and induction of apoptosis. Blood 2003, 101(3):1053-1062. 10.1182/blood-2002-05-1320, 12393461.
36. Halder B, Bhattacharya U, Mukhopadhyay S, Giri AK. Molecular mechanism of black tea polyphenols induced apoptosis in human skin cancer cells: involvement of Bax translocation and mitochondria mediated death cascade. Carcinogenesis 2008, 29(1):129-138.
37. El Abdellaoui S, Destandau E, Toribio A, Elfakir C, Lafosse M, Renimel I, Andre P, Cancellieri P, Landemarre L. Bioactive molecules in Kalanchoe pinnata leaves: extraction, purification, and identification. Anal Bioanal Chem 2010, 398(3):1329-1338. 10.1007/s00216-010-4047-3, 20714893.
38. Anjoo Kamboj A. Bryophyllum pinnatum (Lam.) Kurz.: Phytochemical and pharmacological profile: A review. Pharmacognosy Rev 2009, 3(6):364-374.
39. Yamagishi T, Yan XZ, Wu RY, McPhail DR, McPhail AT, Lee KH. Structure and stereochemistry of bryophyllin-A, a novel potent cytotoxic bufadienolide orthoacetate from Bryophyllum pinnatum. Chem Pharm Bull(Tokyo) 1988, 36(4):1615-1617.
40. Supratman U, Fujita T, Akiyama K, Hayashi H. New insecticidal bufadienolide, bryophyllin C, from Kalanchoe pinnata. Biosci Biotechnol Biochem 2000, 64(6):1310-1312. 10.1271/bbb.64.1310, 10923811.
41. Supratman U, Fujita T, Akiyama K, Hayashi H, Murakami A, Sakai H, Koshimizu K, Ohigashi H. Anti-tumor promoting activity of bufadienolides from Kalanchoe pinnata and K. daigremontiana x tubiflora. Biosci Biotechnol Biochem 2001, 65(4):947-949. 10.1271/bbb.65.947, 11388478.
42. Toshihiro Akihisa WCMCK, Tamura T, Matsumoto T. Sterols ofKalanchoe pinnata: First report of the isolation of both C-24 epimers of 24-alkyl-Δ25-sterols from a higher plant. Lipids 1991, 26(8):660-665.
43. Salimuzzaman Siddiqui SF, Siddiqui Bina S, Naheed S. Triterpenoids and phenanthrenes from leaves of Bryophyllum pinnatum. Phytochemistry 1989, 28(9):2433-2438.
44. Wu PL, Hsu YL, Wu TS, Bastow KF, Lee KH. Kalanchosides A-C, new cytotoxic bufadienolides from the aerial parts of Kalanchoe gracilis. Org Lett 2006, 8(23):5207-5210. 10.1021/ol061873m, 17078679.